Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
-
Syros Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
-
Syros Pharmaceuticals (SYRS) to Raise Approximately $190 Million Through Merger with TYME Technologies (TYME) and Concurrent Private Placement
-
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
-
Syros to Participate in Upcoming Virtual Investor Conferences in March
-
Syros to Participate in Upcoming Investor Conferences in March
-
Syros Pharmaceuticals (SYRS) Prices 5.4M Share Common Offering at $14/Sh
-
Syros Announces Pricing of $75.6 Million Public Offering of Common Stock
-
Syros Pharmaceuticals (SYRS) Announces Proposed Offering of Common Stock
-
Syros Announces Proposed Offering of Common Stock
-
Syros to Present at Upcoming Investor Conferences in March
-
Syros Announces Closing of Concurrent Public Offerings
-
Syros Pharmaceuticals (SYRS) Announces Pricing of $70 Million Concurrent Public Offerings
-
Syros Announces Pricing of $70 Million Concurrent Public Offerings
-
Syros Pharmaceuticals (SYRS) Proposed Concurrent Offerings of Common Stock with Warrants and Preferred Stock with Warrants
-
Syros Announces Proposed Concurrent Public Offerings of Common Stock with Warrants to Purchase Common Stock and Preferred Stock with Warrants to Purchase Common Stock
-
Syros to Participate in Upcoming Investor Conferences in March
-
Syros to Present at Upcoming Investor Conferences
-
Syros Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
-
Syros Pharmaceuticals (SYRS) Prices 4.19M Share Common Offering at $9.55/Sh
-
Syros Announces Pricing of $40 Million Public Offering of Common Stock
-
Syros Pharmaceuticals (SYRS) Announces Proposed $40M Offering of Common Stock
-
Syros Announces Proposed Offering of Common Stock
-
Syros Pharmaceuticals (SYRS) Announces $35M Common Stock Private Placement
-
Syros Announces $35 Million Private Placement
-
Syros Pharmaceuticals to Present at Upcoming Investor Conferences
-
Cowen Starts Syros Pharmaceuticals (SYRS) at Outperform
-
Syros Pharmaceuticals Announces Closing of Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
-
Syros Pharmaceuticals (SYRS) IPO Opens Up 20%
-
Syros Pharmaceuticals (SYRS) Prices 4M Common Stock IPO at $12.50/Share, Under Expected Range
-
Syros Pharmaceuticals Announces Pricing of Initial Public Offering